TrialFrontiers in immunology2024

Clinical trial: Chidamide plus CHOP improve the survival of newly diagnosed angioimmunoblastic T-cell lymphoma.

Xiangping Zong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.